Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

It has been proposed that mannose-binding lectin (MBL) interactions with agalactosyl forms of IgG immunoglobulins found in rheumatoid synovial fluid might lead to enhanced complement activation, an important mediator of the joint damage in rheumatoid arthritis (RA). In order to investigate this possible link between increased MBL-mediated activation of complement and perpetuation of rheumatoid synovitis, we have compared the frequency of an allelic form of MBL, known to be incapable of activating complement, in a group of hospital patients with severe RA and control subjects. No evidence was found to support an association between the presence of this MBL allele and protection from rheumatoid disease; genotype frequencies were similar in both groups. This suggests that complement activation via MBL-agalactosyl IgG complexes is unlikely to play a major role in the pathophysiology of RA.

Original publication

DOI

10.1093/rheumatology/37.2.186

Type

Journal article

Journal

Br J Rheumatol

Publication Date

02/1998

Volume

37

Pages

186 - 188

Keywords

Adult, Aged, Alleles, Arthritis, Rheumatoid, Carrier Proteins, Collectins, Complement Activation, DNA Primers, Female, Gene Frequency, Humans, Male, Middle Aged, Polymorphism, Genetic, Rheumatoid Factor, Rheumatoid Nodule